| Endometrial Neoplasms |
| Recruiting | 4 | 1300 | Europe | Biomarker (ER/PR) guided lymphadenectomy, Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer | Haukeland University Hospital | Endometrial Cancer | 12/20 | 12/33 | | |
NCT01267461: Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells |
|
|
| Available | N/A | | RoW | Tissue sample from tumor | Meir Medical Center, Tel Aviv University | Endometrial Cancer, Colon Cancer | | | | |
| Active, not recruiting | N/A | 240 | RoW | TH, TH/BSO, BPLND | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
NCT01198171: Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 243 | US | Laboratory Biomarker Analysis, Study of Socioeconomic and Demographic Variables | Gynecologic Oncology Group, National Cancer Institute (NCI) | Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 3600 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |